Search
Aytu Biopharma Inc
AYTUAdd to Watchlist
2.310USD
+0.205+9.74%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
24.79MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
ADHD portfolio
13.22M
87.15%
Pediatric portfolio
1.69M
11.14%
EXXUA
241.00K
1.59%
Other
19.00K
0.13%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
ADHD portfolio
13.22M
87.15%
Pediatric portfolio
1.69M
11.14%
EXXUA
241.00K
1.59%
Other
19.00K
0.13%
